Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 DiabetesDiabetes (New York, N.Y.), 2018-07, Vol.67 (7), p.1414-1427 [Peer Reviewed Journal]2018 by the American Diabetes Association. ;Copyright American Diabetes Association Jul 1, 2018 ;2018 by the American Diabetes Association. 2018 ;ISSN: 0012-1797 ;ISSN: 1939-327X ;EISSN: 1939-327X ;DOI: 10.2337/db17-0914 ;PMID: 29703844Full text available |
|
2 |
Material Type: Article
|
The immunology of atherosclerosisNature reviews. Nephrology, 2017-06, Vol.13 (6), p.368-380 [Peer Reviewed Journal]Copyright Nature Publishing Group Jun 2017 ;ISSN: 1759-5061 ;ISSN: 1759-507X ;EISSN: 1759-507X ;DOI: 10.1038/nrneph.2017.51 ;PMID: 28392564Full text available |
|
3 |
Material Type: Article
|
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus InfectionClinical infectious diseases, 2018-10, Vol.67 (10), p.1477-1492 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2018 ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciy585 ;PMID: 30215672Full text available |
|
4 |
Material Type: Article
|
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysisEuropean heart journal, 2022-02, Vol.43 (6), p.474-484 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehab777 ;PMID: 35023547Full text available |
|
5 |
Material Type: Article
|
Targeting the progression of chronic kidney diseaseNature reviews. Nephrology, 2020-05, Vol.16 (5), p.269-288 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;ISSN: 1759-5061 ;EISSN: 1759-507X ;DOI: 10.1038/s41581-019-0248-y ;PMID: 32060481Full text available |
|
6 |
Material Type: Article
|
Empagliflozin in Patients with Chronic Kidney DiseaseThe New England journal of medicine, 2023-01, Vol.388 (2), p.117-127 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2204233 ;PMID: 36331190Full text available |
|
7 |
Material Type: Article
|
Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney diseaseBMJ (Online), 2024-04, Vol.385 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.q721 ;PMID: 38621785Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureThe New England journal of medicine, 2020-10, Vol.383 (15), p.1413-1424 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2022190 ;PMID: 32865377Full text available |
|
9 |
Material Type: Article
|
Dapagliflozin in Patients with Chronic Kidney DiseaseThe New England journal of medicine, 2020-10, Vol.383 (15), p.1436-1446 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2024816 ;PMID: 32970396Full text available |
|
10 |
Material Type: Article
|
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysisGut, 2022-01, Vol.71 (1), p.156-162 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2020-323082 ;PMID: 33303564Full text available |
|
11 |
Material Type: Article
|
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 DiabetesThe New England journal of medicine, 2020-12, Vol.383 (23), p.2219-2229 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2025845 ;PMID: 33264825Full text available |
|
12 |
Material Type: Article
|
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19New England Journal of Medicine, 2020-04, Vol.382 (17), p.1653-1659 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMsr2005760 ;PMID: 32227760Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 DiabetesThe New England journal of medicine, 2021-12, Vol.385 (24), p.2252-2263 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2110956 ;PMID: 34449181Full text available |
|
14 |
Material Type: Article
|
Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTANephrology Dialysis Transplantation, 2021-01, Vol.36 (1), p.87-94 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. ;2020. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gfaa314 ;PMID: 33340043Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
Sotagliflozin in Patients with Diabetes and Chronic Kidney DiseaseThe New England journal of medicine, 2021-01, Vol.384 (2), p.129-139 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2030186 ;PMID: 33200891Full text available |
|
16 |
Material Type: Article
|
Risk of Adverse Pregnancy Outcomes in Women with CKDJournal of the American Society of Nephrology, 2015-08, Vol.26 (8), p.2011-2022 [Peer Reviewed Journal]Copyright © 2015 by the American Society of Nephrology. ;Copyright © 2015 by the American Society of Nephrology 2015 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/ASN.2014050459 ;PMID: 25766536Full text available |
|
17 |
Material Type: Article
|
Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)Nephrology, dialysis, transplantation, 2021-08, Vol.36 (9), p.1616-1628 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA. ;ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gfab191 ;PMID: 34077510Full text available |
|
18 |
Material Type: Article
|
Fatigue in CKD: Epidemiology, Pathophysiology, and TreatmentClinical journal of the American Society of Nephrology, 2021-09, Vol.16 (9), p.1445-1455 [Peer Reviewed Journal]Copyright © 2021 by the American Society of Nephrology. ;Copyright © 2021 by the American Society of Nephrology 2021 ;ISSN: 1555-9041 ;EISSN: 1555-905X ;DOI: 10.2215/CJN.19891220 ;PMID: 33858827Full text available |
|
19 |
Material Type: Article
|
Nutritional Management of Chronic Kidney DiseaseThe New England journal of medicine, 2017-11, Vol.377 (18), p.1765-1776 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra1700312 ;PMID: 29091561Full text available |
|
20 |
Material Type: Article
|
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysisJAMA : the journal of the American Medical Association, 2016-01, Vol.315 (2), p.164 [Peer Reviewed Journal]ISSN: 1538-3598 ;EISSN: 1538-3598 ;DOI: 10.1001/jama.2015.18202Digital Resources/Online E-Resources |